Jaejin An to Comorbidity
This is a "connection" page, showing publications Jaejin An has written about Comorbidity.
Connection Strength
0.817
-
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
Score: 0.159
-
Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis. Clin Rheumatol. 2019 Oct; 38(10):2717-2726.
Score: 0.143
-
Association between different types of comorbidity and disease burden in patients with diabetes. J Diabetes. 2019 Jan; 11(1):65-74.
Score: 0.135
-
Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting. Arthritis Care Res (Hoboken). 2016 05; 68(5):629-37.
Score: 0.116
-
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice. J Am Heart Assoc. 2015 Jul 17; 4(7).
Score: 0.109
-
Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension. Med Care. 2013 Oct; 51(10):879-87.
Score: 0.097
-
Cost of Hospitalization Associated With Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults. J Infect Dis. 2020 08 17; 222(6):962-966.
Score: 0.039
-
The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation. Value Health. 2010 Sep-Oct; 13(6):846-52.
Score: 0.020